TL;DR: The Centers for Medicare & Medicaid Services modified NCD 180 for hemorheograph services, effective March 7, 2026. Coverage is limited to preoperative and postoperative diagnostic evaluation of suspected peripheral artery disease — and this policy lists no specific CPT or HCPCS codes, which creates real documentation and coding risk for your billing team.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Hemorheograph — NCD 180 |
| Policy Code | NCD 180 in the Medicare NCD system |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Podiatry, vascular surgery, general surgery, peripheral vascular diagnostic testing |
| Key Action | Confirm your hemorheograph claims document preoperative or postoperative evaluation of peripheral artery disease — not general skin perfusion assessment |
CMS Hemorheograph Coverage Criteria and Medical Necessity Requirements 2026
NCD 180 is the National Coverage Determination governing Medicare coverage of hemorheograph diagnostic services. The Centers for Medicare & Medicaid Services classifies this under the Diagnostic Tests (other) benefit category.
The CMS hemorheograph coverage policy has a narrow scope. Medicare pays for hemorheograph services only when the procedure is performed for preoperative or postoperative diagnostic evaluation of suspected peripheral artery disease. That's the full extent of covered use.
The policy does acknowledge the hemorheograph's clinical role. It's described as safe and effective for determining the adequacy of skin perfusion before minor surgical procedures on the extremities — including minor podiatric procedures — and as an adjunct to evaluating patients suspected of having peripheral vascular disease. But "safe and effective" doesn't mean "always covered." Medical necessity under this coverage policy is tied specifically to the perioperative evaluation context.
If your practice uses a hemorheograph for general screening or routine vascular assessment outside a surgical context, those claims don't meet medical necessity under this NCD. That's a clean denial risk. Document the clinical indication clearly — preoperative or postoperative, suspected peripheral artery disease — before you submit.
Prior authorization isn't mentioned in this NCD as a specific requirement. That said, your Medicare Administrative Contractor may apply additional local coverage determination requirements on top of this NCD. Check with your MAC before assuming this NCD alone governs all coverage decisions in your region.
CMS Hemorheograph Exclusions and Non-Covered Indications
This NCD contains a critical technical distinction that your billing team needs to understand before coding.
The hemorheograph is not a plethysmograph. CMS makes this explicit. A plethysmograph measures and records changes in the size of a body part as modified by blood circulation. The hemorheograph measures surface blood flow in the skin. It does not measure total blood flow in a digit or limb.
Why does this matter for hemorheograph billing? Because plethysmography has its own set of CPT codes and coverage rules. If a provider or coder conflates the two instruments and uses plethysmography codes to bill hemorheograph services, that's a miscoded claim. It's also the kind of error that shows up in MAC audits.
The real issue here is that coders who aren't familiar with both instruments may reach for familiar plethysmography codes by default. The policy exists partly to prevent that. Train your coding staff on the distinction. It's a short conversation that prevents a painful reimbursement clawback.
Any use of the hemorheograph that falls outside preoperative or postoperative evaluation of suspected peripheral artery disease is not covered under this NCD. That includes using it solely as a standalone diagnostic tool for general peripheral vascular disease screening without a surgical procedure in the picture.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Preoperative evaluation of suspected peripheral artery disease | Covered | Not specified in NCD | Must document surgical context and clinical indication |
| Postoperative evaluation of suspected peripheral artery disease | Covered | Not specified in NCD | Must document surgical context and clinical indication |
| Adjunct evaluation of suspected peripheral vascular disease (surgical context) | Covered | Not specified in NCD | Adjunct role — not standalone screening |
| General skin perfusion assessment without surgical context | Not Covered | N/A | Falls outside NCD 180 medical necessity criteria |
| Plethysmography or total blood flow measurement | Not Covered | N/A | Hemorheograph is explicitly not a plethysmograph under this NCD |
CMS Hemorheograph Billing Guidelines and Action Items 2026
This is where the policy's ambiguity becomes a practical problem. NCD 180 sets clear coverage criteria but lists no CPT or HCPCS codes. That puts the coding burden entirely on your team. Here's how to handle it.
| # | Action Item |
|---|---|
| 1 | Audit your current hemorheograph claims before March 7, 2026. Pull any claim where a hemorheograph was used and verify the documented indication matches the NCD criteria. If the documentation says "skin perfusion assessment" without linking to a perioperative surgical context and suspected peripheral artery disease, flag it for clinical documentation improvement before the effective date. |
| 2 | Contact your MAC directly about coding guidance. Because NCD 180 doesn't list specific CPT or HCPCS codes, your Medicare Administrative Contractor is your best source for which codes to use. Don't guess. A claim denial based on incorrect code selection is harder to appeal than one with solid documentation but a disputed indication. |
| 3 | Train coders on the hemorheograph vs. plethysmograph distinction. This is spelled out in the NCD for a reason. If your coders are pulling plethysmography codes for hemorheograph procedures, you have a systematic miscoding problem. Run a targeted education session before the effective date of March 7, 2026. |
| 4 | Update your documentation templates for procedures using the hemorheograph. The template should prompt providers to record the surgical context (preoperative or postoperative), the suspected diagnosis (peripheral artery disease), and the clinical reason for using the hemorheograph as part of that evaluation. Vague documentation is the fastest route to a claim denial under this NCD. |
| 5 | Check whether your MAC has a local coverage determination that overlaps with NCD 180. A local coverage determination from your MAC could restrict coverage further or clarify coding. NCD 180 is a national floor, not a ceiling. Your MAC can be more restrictive. Review current LCDs for peripheral vascular diagnostic testing in your region. |
| 6 | Flag prior authorization requirements at the payer level, not just Medicare. If your practice also bills commercial payers for hemorheograph services, those payers have separate coverage policies. Some commercial plans may require prior authorization for diagnostic vascular studies. Confirm requirements payer by payer before assuming Medicare billing guidelines apply across the board. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Hemorheograph Services Under NCD 180
Covered CPT/HCPCS Codes
NCD 180 does not list specific CPT or HCPCS codes. This is a significant gap in the policy. Your billing team cannot rely on this NCD alone for code selection.
Contact your Medicare Administrative Contractor to confirm which procedure codes are appropriate for hemorheograph services in your region. Document that conversation and keep it on file. If your MAC provides written guidance, treat it as binding for your claims submission process.
| Code | Type | Description |
|---|---|---|
| Not specified | — | NCD 180 does not identify specific CPT or HCPCS codes for hemorheograph services |
Key ICD-10-CM Diagnosis Codes
NCD 180 does not list specific ICD-10-CM diagnosis codes. Based on the policy criteria — suspected peripheral artery disease, preoperative or postoperative context — your diagnosis coding should reflect that clinical picture. Work with your clinical documentation improvement team and your MAC to identify appropriate diagnosis codes for your claims.
| Code | Description |
|---|---|
| Not specified | NCD 180 does not identify specific ICD-10-CM codes — confirm with your MAC |
The absence of specific codes in this NCD is the single biggest operational risk it creates for your billing team. Don't treat this as a minor administrative detail. A claim submitted with the wrong procedure code — even with perfect documentation — will deny. Get MAC guidance in writing before the effective date.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.